Lung Cancers Completed Phase 1 / 2 Trials for Dasatinib (DB01254)

Also known as: LUng Cancer / Cancer, Lung / Lung neoplasm malignant / Lung cancer NOS / Cancer of lung / Ca lung

IndicationStatusPhase
DBCOND0072929 (Lung Cancers)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00826449Dasatinib and Erlotinib in Non-Small Cell Lung Cancer (NSCLC)Treatment